Literature DB >> 17028491

Obstructive sleep apnea syndrome.

L Michael Prisant1, Thomas A Dillard, Amy R Blanchard.   

Abstract

Obstructive sleep apnea syndrome is caused by upper airway collapse during inspiration, causing intermittent hypoxemia, hypercapnia, acidosis, sympathetic nervous system activation, and arousal from sleep. Nighttime blood pressure is higher, but unexpectedly, daytime hypertension occurs. The prevalence of hypertension is very high and the incidence of hypertension increases as the number of apneic and hypopneic events per hour rises. Obesity is a major predisposing factor for the development of obstructive sleep apnea. Daytime sleepiness, snoring, and breathing pauses are important symptoms to elicit from the patient or sleep partner. Resistant hypertension is an important clue. Overnight polysomnography is required for diagnosis. Weight loss, avoidance of nocturnal sedatives, cessation of evening alcohol ingestion, and avoidance of the supine position during sleep are initial therapeutic actions in mild obstructive sleep apnea syndrome. Continuous positive airway pressure is the treatment of choice for patients unable to find relief from lifestyle changes. Blood pressure modestly improves with treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028491      PMCID: PMC8109598          DOI: 10.1111/j.1524-6175.2006.888139.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  30 in total

Review 1.  Obstructive sleep apnoea.

Authors:  Atul Malhotra; David P White
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

2.  Sleep-related hypoventilation: the evolving role of leptin.

Authors:  Charles W Atwood
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

3.  Obstructive sleep apnea-hypopnea and neurocognitive functioning in the Sleep Heart Health Study.

Authors:  Stuart F Quan; Ron Wright; Carol M Baldwin; Kristine L Kaemingk; James L Goodwin; Tracy F Kuo; Alfred Kaszniak; Lori L Boland; Elise Caccappolo; Richard R Bootzin
Journal:  Sleep Med       Date:  2006-07-03       Impact factor: 3.492

4.  Day-night pattern of sudden death in obstructive sleep apnea.

Authors:  Apoor S Gami; Daniel E Howard; Eric J Olson; Virend K Somers
Journal:  N Engl J Med       Date:  2005-03-24       Impact factor: 91.245

5.  Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study.

Authors:  Reena Mehra; Emelia J Benjamin; Eyal Shahar; Daniel J Gottlieb; Rawan Nawabit; H Lester Kirchner; Jayakumar Sahadevan; Susan Redline
Journal:  Am J Respir Crit Care Med       Date:  2006-01-19       Impact factor: 21.405

6.  Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome.

Authors:  J F Faccenda; T W Mackay; N A Boon; N J Douglas
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

7.  Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study.

Authors:  Donald C Haas; Gregory L Foster; F Javier Nieto; Susan Redline; Helaine E Resnick; John A Robbins; Terry Young; Thomas G Pickering
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

8.  APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study.

Authors:  D J Gottlieb; A L DeStefano; D J Foley; E Mignot; S Redline; R J Givelber; T Young
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

Review 9.  Obesity, sleep apnea, and hypertension.

Authors:  Robert Wolk; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

Review 10.  Blunted nocturnal decline in blood pressure.

Authors:  L Michael Prisant
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-10       Impact factor: 3.738

View more
  8 in total

1.  Intermittent hypercapnic hypoxia induced protein changes in the piglet hippocampus identified by MALDI-TOF-MS.

Authors:  Samantha Tang; Rita Machaalani; Mohammad A Kashem; Izuru Matsumoto; Karen A Waters
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 2.  Sleep apnea and cervical spine pathology.

Authors:  Adam Khan; Khoi D Than; Kevin S Chen; Anthony C Wang; Frank La Marca; Paul Park
Journal:  Eur Spine J       Date:  2013-10-09       Impact factor: 3.134

3.  Cervical vertebral column morphology in patients with obstructive sleep apnoea assessed using lateral cephalograms and cone beam CT. A comparative study.

Authors:  L Sonnesen; K E Jensen; A R Petersson; N Petri; S Berg; P Svanholt
Journal:  Dentomaxillofac Radiol       Date:  2013-03-15       Impact factor: 2.419

4.  The effect of nightly nasal CPAP treatment on nocturnal hypoxemia and sleep disorders in mustard gas-injured patients.

Authors:  Ensieh Vahedi; Ali Reza Fazeli Varzaneh; Mostafa Ghanei; Shahla Afsharpaiman; Zohre Poursaleh
Journal:  Sleep Breath       Date:  2014-01-16       Impact factor: 2.816

Review 5.  Resistant hypertension.

Authors:  Sheldon W Tobe; Richard Lewanczuk
Journal:  Can J Cardiol       Date:  2009-05       Impact factor: 5.223

6.  Pharyngeal Airway Dimensions and Head Posture in Obstructive Sleep Apnea Patients with and without Morphological Deviations in the Upper Cervical Spine.

Authors:  Liselotte Sonnesen; Arne Petersson; Søren Berg; Palle Svanholt
Journal:  J Oral Maxillofac Res       Date:  2017-09-30

7.  Therapeutic effect of laparoscopic sleeve gastrectomy on obstructive sleep apnea and relationship of type 2 diabetes in Japanese patients with severe obesity.

Authors:  Shingo Yanari; Akira Sasaki; Akira Umemura; Yasushi Ishigaki; Haruka Nikai; Tsuguo Nishijima; Shigeru Sakurai
Journal:  J Diabetes Investig       Date:  2022-02-08       Impact factor: 3.681

8.  Interrelationships between obesity, obstructive sleep apnea syndrome and cardiovascular risk in obese adolescents.

Authors:  D Koren; J A Chirinos; L E L Katz; E R Mohler; P R Gallagher; G F Mitchell; C L Marcus
Journal:  Int J Obes (Lond)       Date:  2015-05-18       Impact factor: 5.095

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.